Cargando…
Aortic stenosis: a review on acquired pathogenesis and ominous combination with diabetes mellitus
BACKGROUND: Aortic stenosis (AS) is a progressive disease, with no pharmacological treatment. The prevalence of diabetes mellitus (DM) among AS patients is higher than in the general population. DM significantly increases the risk of AS development and progression from mild to severe. The interplay...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082141/ https://www.ncbi.nlm.nih.gov/pubmed/37027109 http://dx.doi.org/10.1186/s43044-023-00345-6 |
_version_ | 1785021256483995648 |
---|---|
author | Wal, Pranay Rathore, Shruti Aziz, Namra Singh, Yash Kumar Gupta, Arpit |
author_facet | Wal, Pranay Rathore, Shruti Aziz, Namra Singh, Yash Kumar Gupta, Arpit |
author_sort | Wal, Pranay |
collection | PubMed |
description | BACKGROUND: Aortic stenosis (AS) is a progressive disease, with no pharmacological treatment. The prevalence of diabetes mellitus (DM) among AS patients is higher than in the general population. DM significantly increases the risk of AS development and progression from mild to severe. The interplay between AS and DM's mechanism is not entirely known yet. MAIN BODY: The increased accumulation of advanced glycation end products (AGEs) was linked to increased valvular oxidative stress, inflammation, expression of coagulation factors, and signs of calcification, according to an analysis of aortic stenotic valves. It is interesting to note that in diabetic AS patients, valvular inflammation did not correlate with serum glucose levels but rather only with long-term glycemic management markers like glycated haemoglobin and fructosamine. Transcatheter aortic valve replacement, which has been shown to be safer than surgical aortic valve replacement, is advantageous for AS patients who also have concurrent diabetes. Additionally, novel anti-diabetic medications have been proposed to lower the risk of AS development in DM patients, including sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonist that target reduction of AGEs-mediated oxidative stress. CONCLUSIONS: There are little data on the effects of hyperglycemia on valvular calcification, but understanding the interactions between them is essential to develop a successful treatment strategy to stop or at least slow the progression of AS in DM patients. There is a link among AS and DM and that DM negatively impacts the quality of life and longevity of AS patients. The sole successful treatment, despite ongoing efforts to find new therapeutic modalities, involves aortic valve replacement. More research is required to find methods that can slow the advancement of these conditions, enhancing the prognosis and course of people with AS and DM. GRAPHICAL ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-10082141 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-100821412023-04-09 Aortic stenosis: a review on acquired pathogenesis and ominous combination with diabetes mellitus Wal, Pranay Rathore, Shruti Aziz, Namra Singh, Yash Kumar Gupta, Arpit Egypt Heart J Review BACKGROUND: Aortic stenosis (AS) is a progressive disease, with no pharmacological treatment. The prevalence of diabetes mellitus (DM) among AS patients is higher than in the general population. DM significantly increases the risk of AS development and progression from mild to severe. The interplay between AS and DM's mechanism is not entirely known yet. MAIN BODY: The increased accumulation of advanced glycation end products (AGEs) was linked to increased valvular oxidative stress, inflammation, expression of coagulation factors, and signs of calcification, according to an analysis of aortic stenotic valves. It is interesting to note that in diabetic AS patients, valvular inflammation did not correlate with serum glucose levels but rather only with long-term glycemic management markers like glycated haemoglobin and fructosamine. Transcatheter aortic valve replacement, which has been shown to be safer than surgical aortic valve replacement, is advantageous for AS patients who also have concurrent diabetes. Additionally, novel anti-diabetic medications have been proposed to lower the risk of AS development in DM patients, including sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonist that target reduction of AGEs-mediated oxidative stress. CONCLUSIONS: There are little data on the effects of hyperglycemia on valvular calcification, but understanding the interactions between them is essential to develop a successful treatment strategy to stop or at least slow the progression of AS in DM patients. There is a link among AS and DM and that DM negatively impacts the quality of life and longevity of AS patients. The sole successful treatment, despite ongoing efforts to find new therapeutic modalities, involves aortic valve replacement. More research is required to find methods that can slow the advancement of these conditions, enhancing the prognosis and course of people with AS and DM. GRAPHICAL ABSTRACT: [Image: see text] Springer Berlin Heidelberg 2023-04-07 /pmc/articles/PMC10082141/ /pubmed/37027109 http://dx.doi.org/10.1186/s43044-023-00345-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Wal, Pranay Rathore, Shruti Aziz, Namra Singh, Yash Kumar Gupta, Arpit Aortic stenosis: a review on acquired pathogenesis and ominous combination with diabetes mellitus |
title | Aortic stenosis: a review on acquired pathogenesis and ominous combination with diabetes mellitus |
title_full | Aortic stenosis: a review on acquired pathogenesis and ominous combination with diabetes mellitus |
title_fullStr | Aortic stenosis: a review on acquired pathogenesis and ominous combination with diabetes mellitus |
title_full_unstemmed | Aortic stenosis: a review on acquired pathogenesis and ominous combination with diabetes mellitus |
title_short | Aortic stenosis: a review on acquired pathogenesis and ominous combination with diabetes mellitus |
title_sort | aortic stenosis: a review on acquired pathogenesis and ominous combination with diabetes mellitus |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082141/ https://www.ncbi.nlm.nih.gov/pubmed/37027109 http://dx.doi.org/10.1186/s43044-023-00345-6 |
work_keys_str_mv | AT walpranay aorticstenosisareviewonacquiredpathogenesisandominouscombinationwithdiabetesmellitus AT rathoreshruti aorticstenosisareviewonacquiredpathogenesisandominouscombinationwithdiabetesmellitus AT aziznamra aorticstenosisareviewonacquiredpathogenesisandominouscombinationwithdiabetesmellitus AT singhyashkumar aorticstenosisareviewonacquiredpathogenesisandominouscombinationwithdiabetesmellitus AT guptaarpit aorticstenosisareviewonacquiredpathogenesisandominouscombinationwithdiabetesmellitus |